Scancell Attendance at Upcoming Conferences
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, is pleased to confirm that it will be presenting at, and will also attend, several upcoming conferences and events. Presentations at these high-profile conferences follow the significant recent progress that Scancell has made in both pre-clinical and clinical development.
These include:
- 14th World ADC taking place in London, UK from 12-15 March.
Mandeep Sehmi, Head of Business Development, will be presenting at the conference.
Title: Glymab ADC for targeting cancers with high unmet need
Date and Time: Wednesday 13th March 5pm GMT
- Oxford Global - Biologics 2024 taking place in London, UK from 13-15 March
Poonam Vagehla and Foram Dave, Scientists at Scancell, will be presenting at the conference.
Session Title: Nextgen Multispecifics, Cell Engagers & Other New Modalities
Title: Glycan Targeting Antibodies for T Cell Redirection
Date and Time: Friday 15th March at 3:10 pm GMT
BIO-Europe Spring in Barcelona, Spain from 18-20 March
Mandeep Sehmi, Head of Business Development and Mireille Vankemmelbeke, PI at Scancell will be attending the conference.
- 21st CIMT Annual Meeting taking place in Mainz, Germany from 15-17 May
Samantha Paston, Head of Translational Research, will be attending the conference.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.